1 Day
المصدر:
Financial Times
AstraZeneca Focuses on Rare Diseases in $80bn Growth
The chief executive of Alexion stated that the market for rare disease medicines remains largely underdeveloped and presents significant growth opportunities.
articleDetails.fontSize.sizeحجم النص
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading